SENSITIVITY, SPECIFICITY, AND PREDICTIVE VALUE OF FECAL OCCULT BLOOD TESTING (HEMOCCULT-II) FOR COLORECTAL NEOPLASIA IN SYMPTOMATIC PATIENTS - A PROSPECTIVE-STUDY WITH TOTAL COLONOSCOPY

Authors
Citation
Y. Niv et Ad. Sperber, SENSITIVITY, SPECIFICITY, AND PREDICTIVE VALUE OF FECAL OCCULT BLOOD TESTING (HEMOCCULT-II) FOR COLORECTAL NEOPLASIA IN SYMPTOMATIC PATIENTS - A PROSPECTIVE-STUDY WITH TOTAL COLONOSCOPY, The American journal of gastroenterology, 90(11), 1995, pp. 1974-1977
Citations number
24
Categorie Soggetti
Gastroenterology & Hepatology
ISSN journal
00029270
Volume
90
Issue
11
Year of publication
1995
Pages
1974 - 1977
Database
ISI
SICI code
0002-9270(1995)90:11<1974:SSAPVO>2.0.ZU;2-V
Abstract
Objectives: To evaluate the specificity, sensitivity, and positive pre dictive value of fecal occult blood testing (FOBT) in symptomatic pati ents, with colonoscopy as the gold standard, and to assess the usefuln ess of FOBT as an ancillary examination in symptomatic patients for wh om total colonoscopy is indicated. Methods: We studied 439 consecutive patients who underwent Hemoccult II testing before total colonoscopy, Results: The sensitivity, specificity, and positive predictive value for colorectal neoplasia (cancer and adenomatous polyps) was 76.5%, 56 .7%, and 27.6%, respectively, The sensitivity, specificity, and positi ve predictive value for colorectal cancer were 69.2%, 73.2%, and 7.3%, respectively, Conclusions: The sensitivity, specificity, and positive predictive value of FOBT are difficult to estimate from screening pro grams, because Hemoccult-negative individuals do not undergo examinati on of the colon, and many of the Hemoccult-positive cases do not under go total colonoscopy. With total colonoscopy serving as the gold stand ard, FOBT does not appear to be of much value as an ancillary examinat ion in patients with symptoms potentially attributable to the lower ga strointestinal tract.